TELEO Capital Acquires Modersys (SmartFactory Rx) From Applied Materials
June 23, 2026
TELEO Capital Management acquired SmartFactory Rx, which has been rebranded as Modersys, from Applied Materials. Modersys is a pharmaceutical manufacturing intelligence platform that uses real-time analytics, AI/ML process intelligence, and advanced process control to help regulated life sciences manufacturers improve yield, reduce variability, and accelerate time to market.
- Targets
- Modersys (fka SmartFactory Rx)
- Sellers
- Applied Materials, Inc.
- Industry
- Software
- Location
- Idaho, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
D2 Solutions Acquires ProModRx
April 16, 2026
Healthcare Services
D2 Solutions, a healthcare consulting and technology company focused on market access and patient support, acquired ProModRx, a cloud-based patient access technology platform. The acquisition is designed to expand D2’s ability to support pharma and medical device manufacturers across the full patient journey, strengthening its UltraTouch Verify and UltraTouch Engage offerings.
-
Aptar Pharma Acquires Mod3 Pharma's Clinical Trial Materials Manufacturing Capabilities
July 15, 2025
Pharmaceuticals
Aptar Pharma has acquired the Phase 1 and 2 clinical trial materials manufacturing capabilities of Mod3 Pharma (formerly Enteris Biopharma) from SWK Holdings. The deal adds cGMP fill-and-finish, high-potency API suites and biologics capabilities at a Boonton, New Jersey facility to Aptar's drug delivery and early-stage development services to accelerate adoption of its delivery technologies.
-
TELEO Capital Acquires SOFTRAX from TELUS Corporation
February 27, 2025
Cloud & SaaS
TELEO Capital Management has acquired SOFTRAX, a Boise-based provider of cloud revenue management and billing software, from TELUS Corporation. TELEO says the investment will accelerate product innovation, integrate advanced analytics/AI capabilities, and support organic and strategic growth initiatives for SOFTRAX.
-
ToxStrategies (Renovus-backed) Acquires Modality Solutions
August 8, 2023
Healthcare Services
ToxStrategies, a Renovus Capital Partners-backed life sciences consulting platform, has acquired Modality Solutions, a Houston-based firm specializing in biopharmaceutical cold-chain optimization and shipping validation testing. The add-on expands ToxStrategies' cold-chain, package engineering, and regulatory testing capabilities and will operate as a division of ToxStrategies with Modality's founders continuing to lead the business.
-
TELEO Capital Acquires Majority Stake in Sharpen Technologies (SharpenCX)
December 13, 2022
Cloud & SaaS
TELEO Capital completed a majority control investment in Sharpen Technologies Inc. (SharpenCX), a cloud-native contact center (CCaaS/UCaaS) platform based in Indianapolis. TELEO said it will provide operational resources and capital to accelerate product innovation, expand SharpenCX’s market position, and enhance support and platform capabilities.
-
CPS Capital Makes Growth Investment in PharmaSmart International
July 12, 2021
Medical Devices
Toronto-based private equity firm CPS Capital made a strategic growth investment in PharmaSmart International alongside the company’s existing management team. The financing (which included term debt from FirePower Capital and Nicola Wealth) will fund roll‑out of PharmaSmart’s PS-2000D health kiosk platform and accelerate expansion across Canada and the United States.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.